Literature DB >> 35509677

Self-limited Hypertension Due to Kidney Infarction.

Mario Funes Hernandez1,2, Vivek Bhalla1,2, Robert Tristan Isom1,2.   

Abstract

Entities:  

Year:  2022        PMID: 35509677      PMCID: PMC9058599          DOI: 10.1016/j.xkme.2022.100454

Source DB:  PubMed          Journal:  Kidney Med        ISSN: 2590-0595


× No keyword cloud information.
A woman in her 40s presented for the management of new-onset hypertension. Four months before the presentation, she had undergone revision pancreaticoduodenectomy for a pancreatic neoplasm. The left kidney required manual displacement to facilitate the removal of the tumor and optimize radiotherapy. A postsurgical computed tomography scan showed a new, broad area of segmental hypoperfusion in the lower aspect of the left kidney (Fig 1, arrow). After the surgery, clinic blood pressures were consistently elevated, averaging 160/90 mm Hg. Her plasma renin activity and serum aldosterone level were 8.4 ng/mL per hour and 18 ng/dL, respectively. Losartan normalized the blood pressure. Subsequent imaging showed interval development of cortical atrophy of the previously ischemic parenchyma (Fig 1C, arrow). After several months, her blood pressure returned to normal; losartan was weaned and then discontinued. This case illustrates the development of hypertension due to kidney ischemia, followed by restoration of normotension, after the definitive loss of the affected renin-producing parenchyma. Renovascular hypertension affects 1%-5% of the patients with hypertension. Regardless of the etiology, a pressure drop of 20 mm Hg distal to a flow-limiting lesion can stimulate renin release, potentially producing hypertension. Renovascular hypertension is frequently caused by atherosclerotic kidney artery stenosis or fibromuscular dysplasia; however, other rare conditions that limit perfusion to the kidneys, such as external manipulation, have been described (Item S1).3, 4, 5 Here, we present an unusual case of self-limiting hypertension caused by intrasurgical manipulation and constriction of the kidney artery that resolved once complete kidney ischemia ensued.
Figure 1

(A) A preprocedural computed tomography scan of the abdomen and pelvis with intravenous contrast with symmetric kidneys (arrow). (B) Postsurgical day 6 computed tomography scan with a new geographic region of hypoenhancement in the inferior pole of left kidney consistent with renal hypoperfusion/infarct (arrow). (C) A computed tomography scan 5 months after the surgery with focal atrophy of the inferior pole of the left kidney (arrow).

(A) A preprocedural computed tomography scan of the abdomen and pelvis with intravenous contrast with symmetric kidneys (arrow). (B) Postsurgical day 6 computed tomography scan with a new geographic region of hypoenhancement in the inferior pole of left kidney consistent with renal hypoperfusion/infarct (arrow). (C) A computed tomography scan 5 months after the surgery with focal atrophy of the inferior pole of the left kidney (arrow).
  5 in total

Review 1.  The clinical spectrum of primary renal vasculitis.

Authors:  Michael Samarkos; Sozos Loizou; George Vaiopoulos; Kevin A Davies
Journal:  Semin Arthritis Rheum       Date:  2005-10       Impact factor: 5.532

2.  Longterm Outcomes of Renal Artery Involvement in Takayasu Arteritis.

Authors:  Seokchan Hong; Byeongzu Ghang; Yong-Gil Kim; Chang-Keun Lee; Bin Yoo
Journal:  J Rheumatol       Date:  2017-02-15       Impact factor: 4.666

3.  Assessment of renal artery stenosis severity by pressure gradient measurements.

Authors:  Bernard De Bruyne; Ganesh Manoharan; Nico H J Pijls; Katia Verhamme; Juraj Madaric; Jozef Bartunek; Marc Vanderheyden; Guy R Heyndrickx
Journal:  J Am Coll Cardiol       Date:  2006-10-17       Impact factor: 24.094

Review 4.  Renovascular Hypertension.

Authors:  Sandra M Herrmann; Stephen C Textor
Journal:  Endocrinol Metab Clin North Am       Date:  2019-09-19       Impact factor: 4.741

Review 5.  Beyond Atherosclerosis and Fibromuscular Dysplasia: Rare Causes of Renovascular Hypertension.

Authors:  Alexandre Persu; Caitriona Canning; Magda Januszewicz; Andrzej Januszewicz; Aleksander Prejbisz; Piotr Dobrowolski; Laurence Amar; Constantina Chrysochou; Jacek Kądziela; Mieczysław Litwin; Daan van Twist; Patricia Van der Niepen; Gregoire Wuerzner; Peter de Leeuw; Michel Azizi
Journal:  Hypertension       Date:  2021-08-30       Impact factor: 10.190

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.